Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
J Surg Res ; 300: 272-278, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38830302

ABSTRACT

INTRODUCTION: As outcomes for breast cancer patients improve, addressing the side effects and distress of treatment can optimize survivorship. Although distress in breast cancer is well known in literature, there is a lack of information on how these concerns change through the phases of the cancer care continuum. Therefore, this study investigates the longitudinal trajectory of worry in patients with nonmetastatic breast cancer. METHODS: Female patients with newly diagnosed stage I-III breast cancer comprised a mixed-methods, longitudinal study at a cancer center from June 2019 to June 2023. Patients completed an open-ended survey regarding their top three concerns. Responses were obtained before surgery and two weeks, three, six, nine months, and one year postoperatively. Responses were qualitatively coded and analyzed to determine themes of cancer-related distress. RESULTS: Participants (n = 262) were aged an average 57.53 y (±12.54), 65.8% had stage I disease at diagnosis, and 91.1% were White. Responses revealed that patients' top three sources of concerns varied by treatment phase. Overall, patients were worried about their cancer diagnosis and the risk of recurrence. Preoperatively, patients were worried about treatment timeline, while postoperative concerns transitioned to physical appearance and surgical side effects. CONCLUSIONS: Breast cancer patients consistently reported worries about cancer diagnosis, recurrence, and metastasis as well as the side effects and fear of treatments. However, patient worry appeared to be intrinsically linked with their treatment phase. Therefore, support and interventions should be catered to reflect the changing patterns of patients' sources of distress to optimize breast cancer patients' quality of life.


Subject(s)
Breast Neoplasms , Mastectomy , Humans , Female , Breast Neoplasms/surgery , Breast Neoplasms/psychology , Middle Aged , Aged , Longitudinal Studies , Adult , Mastectomy/psychology , Mastectomy/adverse effects , Anxiety/etiology , Anxiety/psychology , Anxiety/epidemiology , Qualitative Research , Quality of Life , Surveys and Questionnaires/statistics & numerical data , Neoplasm Recurrence, Local/psychology , Neoplasm Recurrence, Local/epidemiology
3.
Ann Surg Oncol ; 30(9): 5667-5680, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37336806

ABSTRACT

BACKGROUND: The objective of this study was to compare postoperative complication rates and healthcare charges between patients who underwent coordinated versus staged breast surgery and bilateral salpingo-oophorectomy (BSO). PATIENTS AND METHODS: The MarketScan administrative database was used to identify adult female patients with invasive breast cancer or BRCA1/BRCA2 mutations who underwent BSO and breast surgery (lumpectomy or mastectomy with or without reconstruction) between 2010 and 2015. Patients were assigned to the coordinated group if a breast operation and BSO were performed simultaneously or assigned to the staged group if BSO was performed separately. Primary outcomes were (1) incidence of 90-day postoperative complications and (2) 2-year aggregate perioperative healthcare charges. Fisher's exact tests, Wilcoxon rank-sum tests, and multivariable regression analyses were performed. RESULTS: Of the 4228 patients who underwent breast surgery and BSO, 412 (9.7%) were in the coordinated group and 3816 (90.3%) were in the staged group. The coordinated group had a higher incidence of postoperative complications (24.0% vs. 17.7%, p < 0.01), higher risk-adjusted odds of postoperative complications [odds ratio (OR) 1.37, 95% confidence interval (CI) 1.06-1.76, p = 0.02], and similar aggregate healthcare charges before (median charges: $106,500 vs. $101,555, p = 0.96) and after risk-adjustment [incidence rate ratio (IRR) 1.00, 95% CI 0.93-1.07; p = 0.95]. In a subgroup analysis, incidence of postoperative complications (12.9% for coordinated operations vs. 11.7% for staged operation, p = 0.73) was similar in patients whose breast operation was a lumpectomy. CONCLUSIONS: While costs were similar, coordinating breast surgery with BSO was associated with more complications in patients who underwent mastectomy, but not in patients who underwent lumpectomy. These data should inform shared decision-making in high-risk patients.


Subject(s)
Breast Neoplasms , Ovarian Neoplasms , Adult , Humans , Female , Mastectomy/adverse effects , Salpingo-oophorectomy/adverse effects , Breast Neoplasms/genetics , Ovarian Neoplasms/surgery , Postoperative Complications/etiology , Postoperative Complications/surgery , Ovariectomy
4.
Surg Clin North Am ; 103(1): 93-106, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36410356

ABSTRACT

Traditionally, surgical therapy for primary breast lesions in stage IV breast cancer has been reserved for palliation. Several retrospective studies have suggested a possible survival benefit with surgical resection of the primary tumor in patients with distant metastases. However, evidence from prospective, randomized controlled trials suggest that locoregional control provides no clear survival advantage for patients with stage IV breast cancer. Future areas of inquiry include identification of subsets of patients who may derive a survival benefit from locoregional control.


Subject(s)
Breast Neoplasms , Humans , Female , Breast Neoplasms/surgery , Retrospective Studies , Prospective Studies , Palliative Care
6.
World J Pediatr Congenit Heart Surg ; 12(3): 426-429, 2021 05.
Article in English | MEDLINE | ID: mdl-31072227

ABSTRACT

Rhabdomyoma of the fetal heart is a rare disease accounting for about 1% of all fetal cardiac structural anomalies. They are often found in association with tuberous sclerosis complex. Large cardiac rhabdomyomas can compromise the cardiac function. We report a case of multiple large rhabdomyomas of the right and left ventricles, affecting the cardiac function, which was successfully treated with the chemotherapeutic and immunosuppressive medication everolimus, in a neonate with genetically confirmed tuberous sclerosis complex with multisystem manifestations. There was rapid involution of the tumors in response to everolimus therapy in this infant.


Subject(s)
Antineoplastic Agents , Heart Neoplasms , Rhabdomyoma , Tuberous Sclerosis , Antineoplastic Agents/therapeutic use , Everolimus/therapeutic use , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/drug therapy , Humans , Infant , Infant, Newborn , Rhabdomyoma/diagnostic imaging , Rhabdomyoma/drug therapy , Tuberous Sclerosis/drug therapy
7.
J Maxillofac Oral Surg ; 19(3): 456-460, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32801544

ABSTRACT

INTRODUCTION: Oral and maxillofacial surgery evolves around the head and neck region, and acts as a connecting bridge between medical and dental specialities. Little is known regarding the scope of oral and maxillofacial surgery among the medical postgraduates; good awareness towards oral and maxillofacial surgery among different branches of medical professionals is essential for better referral and, in turn, for the benefit of the patient. The main objective of this study was to assess the knowledge and awareness of oral and maxillofacial surgery speciality among medical postgraduates. MATERIALS AND METHODS: A questionnaire survey was conducted among 306 medical postgraduates of medical institutions associated with and without dental institutions. RESULTS: In this study, we found that there is a very low awareness of oral and maxillofacial surgery speciality in the medical postgraduates in terms of its scope of service and emphasis should be laid on the public image regarding this speciality.

8.
Pediatr Cardiol ; 41(5): 892-898, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32095851

ABSTRACT

Accurate assessment of LV systolic function remains a challenge, especially in the pediatric population. Myocardial strain measurement by 2D speckle tracking echocardiography (2DSTE) is a relatively new modality for assessment of regional and global myocardial wall motion. This study aims to establish the normative value among various pediatric age groups at a large pediatric tertiary care institution and to describe the challenges encountered in establishing such strain data. Transthoracic echocardiograms were acquired in 121 healthy children (age 0-21 years) and were retrospectively analyzed. The global longitudinal strain (GLS) was obtained by 2D speckle tracking using Philips Epiq7® and QLAB post processing software. The normative value for left ventricular GLS (%) obtained in our study was - 20.8 ± 2.3 (< 1 year); - 21.4 ± 2.2 (1-4 years); - 19.6 ± 2.4 (5-9 years); - 19.4 ± 2.6 (10-14 years); - 18.9 ± 3.0 (15-21 years). There was a statistically significant difference in GLS between the different age groups. The BMI (kg/m2) of assessed subjects were 14.6 ± 2.3 (< 1 year); 16.3 ± 1.5 (1-4 years); 16.7 ± 2.3 (5-9 years); 21.3 ± 4.6 (10-14 years); 23.9 ± 5.9 (15-21 years). There was no significant difference in GLS by gender or by BMI found in our study. We present our experience with establishment of normative values of 2DSTE in our pediatric echocardiography lab. This study shows that age is the major determinant of variation in peak GLS in healthy subjects, emphasizing the importance of establishment of normative data among various age groups in pediatrics.


Subject(s)
Echocardiography/methods , Heart Diseases/physiopathology , Heart Ventricles/diagnostic imaging , Ventricular Function, Left , Adolescent , Age Factors , Child , Child, Preschool , Female , Healthy Volunteers , Heart Diseases/epidemiology , Humans , Infant , Infant, Newborn , Male , Myocardial Contraction , Myocardium , Pediatrics , Retrospective Studies , Young Adult
9.
Dis Colon Rectum ; 63(3): 389-396, 2020 03.
Article in English | MEDLINE | ID: mdl-31842157

ABSTRACT

BACKGROUND: The Controlled Substance Act was enacted in efforts to reduce the abuse and misuse of opioid pain relievers. However, the effects of this regulation on the prescribing patterns of providers has yet to be realized. OBJECTIVE: We sought to identify the changes in opioid-prescribing patterns of an elective colorectal surgical practice as a result of this legislative change. DESIGN: This is a retrospective study of patients undergoing elective colorectal surgery. Patients were intentionally grouped into group A (January 1, 2012 to October 5, 2014) and group B (October 6, 2014 to December 31, 2016) to capture the period surrounding the new legislation. SETTINGS: We evaluated patients undergoing elective colorectal surgery at a single academic center over a 5-year period. PATIENTS: There were 443 patients undergoing elective colorectal surgery between 2012 and 2016. MAIN OUTCOME MEASURES: The primary outcome was total milligram morphine equivalent of pain medication prescribed at discharge. Secondary outcomes included total number of pills prescribed, total milligram morphine equivalent of pain medication at subsequent prescriptions, and numeric postoperative pain scores. RESULTS: Patients in group B were found to have a greater mean total milligram morphine equivalent prescribed at discharge (719 (SD 593) vs 660 (SD 548), p = 0.03), mean total quantity of pills prescribed at discharge (98 (SD 106) vs 87 (SD 63), p = 0.05), and mean total quantity of pills prescribed as subsequent prescriptions (77 (SD 117) vs 68 (SD 83), p = 0.05) compared with group A. On multivariable analysis, group B was a significant predictor of greater total milligram morphine equivalents prescribed at discharge compared with group A (p = 0.01). LIMITATIONS: This study is limited by analysis from a single institution. CONCLUSIONS: Efforts to minimize opioid prescriptions after surgery through legislation could result in unintended consequences. Recognition of this result is important to effectively reduce opioid prescriptions after surgery. See Video Abstract at http://links.lww.com/DCR/B96. UNA CONSECUENCIA NO DESEADA DE UNA NUEVA LEGISLACIÓN DE OPIOIDES: La Ley de Sustancias Controladas se promulgó con el fin de reducir el abuso y el uso indebido de analgésicos opioides. Sin embargo, los efectos de esta regulación en los patrones de prescripción de los proveedores aún no se han realizado.Se intento identificar los cambios en los patrones de prescripción de opioides de una práctica quirúrgica colorrectal electiva como resultado de este cambio legislativo.Este es un estudio retrospectivo de pacientes sometidos a cirugía colorrectal electiva. Los pacientes fueron agrupados intencionalmente en el Grupo A (1 de enero de 2012 al 5 de octubre de 2014) y el Grupo B (6 de octubre de 2014 al 31 de diciembre de 2016) para capturar el período que rodea la nueva legislación.Se evaluaron a los pacientes sometidos a cirugía colorrectal electiva en un solo centro académico durante un período de 5 años.Hubo 443 pacientes que se sometieron a cirugía colorrectal electiva entre 2012-2016.La medida de resultado primaria fue el equivalente de miligramos de morfina total de los analgésicos prescritos al momento del alta. Las medidas de resultado secundarias incluyeron el número total de píldoras prescritas, el equivalente total de miligramos de morfina de la medicación para el dolor en las prescripciones posteriores y las puntuaciones numéricas de dolor postoperatorio.Se encontró que los pacientes en el Grupo B tenían un equivalente de miligramos de morfina total total mayor prescrito al alta (719 [DE 593] v. 660 [DE 548], p = 0.03), cantidad total promedio de píldoras prescritas al alta (98 [SD 106] v. 87 [SD 63], p = 0.05), y la cantidad total promedio de píldoras recetadas como recetas posteriores (77 [SD 117] v. 68 [SD 83], p = 0.05) en comparación con el Grupo A. En análisis multivariable, el Grupo B fue un predictor significativo de mayores equivalentes de morfina en miligramos totales prescritos al alta en comparación con el grupo A (p = 0.01).Este estudio está limitado por el análisis de una sola instituciónLos esfuerzos para minimizar las recetas de opioides después de la cirugía a través de la legislación podrían tener consecuencias no deseadas. El reconocimiento de este resultado es importante para reducir eficazmente las recetas de opioides después de la cirugía. Consulte Video Resumen en http://links.lww.com/DCR/B96.


Subject(s)
Analgesics, Opioid/therapeutic use , Colorectal Surgery , Drug and Narcotic Control/legislation & jurisprudence , Opioid-Related Disorders/prevention & control , Pain, Postoperative/drug therapy , Practice Patterns, Physicians'/statistics & numerical data , Elective Surgical Procedures , Female , Humans , Male , Middle Aged , Retrospective Studies , United States
10.
Pediatr Cardiol ; 41(1): 202-205, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31342117

ABSTRACT

Pediatric cardiology and cardiovascular surgery have witnessed significant advancements over the last two decades. In spite of this progress, congenital heart disease (CHD) still remains as one of the major causes of death in infants and young children in the United States. Many patient-related and patient-independent factors influence the outcomes in patients with CHD, one of which is the geographical location. In the US-Mexico border, management and outcomes of patients with CHD are further complicated by additional problems stemming from complex interplay between two different health systems, and socioeconomic disparities. In this article, the authors evaluate the various interplaying factors and describe the difficulties facing the practicing pediatric cardiologists in a US-Mexico border city.


Subject(s)
Cardiology/organization & administration , Delivery of Health Care/organization & administration , Heart Defects, Congenital/surgery , Cardiology/legislation & jurisprudence , Delivery of Health Care/legislation & jurisprudence , Heart Defects, Congenital/economics , Humans , Infant , International Cooperation , Mexico/ethnology , Texas
11.
Cardiol Young ; 29(3): 270-276, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30585560

ABSTRACT

BACKGROUND: Fetal echocardiography is the main modality of prenatal diagnosis of CHD. This study was done to describe the trends and benefits associated with prenatal diagnosis of complex CHD at a tertiary care centre. METHODS: Retrospective chart review of patients with complex CHD over an 18-year period was performed. Rates of prenatal detection along with early and late infant mortality outcomes were studied. RESULTS: Of 381 complex CHD patients born during the study period, 68.8% were diagnosed prenatally. Prenatal detection rate increased during the study period from low-50s in the first quarter to mid-80s in the last quarter (p=0.001). Rate of detection of conotruncal anomalies increased over the study period. No infant mortality benefit was noted with prenatal detection. CONCLUSIONS: Improved obstetrical screening indications and techniques have contributed to higher proportions of prenatal diagnosis of complex CHD. However, prenatal diagnosis did not confer survival benefits in infancy in our study.

12.
Pediatr Nephrol ; 34(3): 487-494, 2019 03.
Article in English | MEDLINE | ID: mdl-30276536

ABSTRACT

BACKGROUND: Chronic systemic hypertension has a well-known association with increased cardiovascular morbidity and mortality. One of the most important target organs affected in systemic hypertension is the heart. In addition, chronic kidney disease (CKD) further increases the mortality from cardiovascular disease. The aim of this study was to evaluate the differences in the cardiovascular changes in pediatric patients with primary hypertension (pHTN) vs. those with secondary hypertension from chronic kidney disease (CKD-HTN). METHODS: This was a retrospective chart review of patients with CKD-HTN and pHTN. The medical records were reviewed for anthropometric data, biochemical assessment of renal function, and for cardiovascular changes on echocardiogram. RESULTS: Twenty-three patients with pHTN and 29 patients with CKD-HTN were included in the study. There were no differences in age, gender, weight, height, body mass index, and blood pressure between the 2 groups. There was a high prevalence of left ventricular diastolic dysfunction among both the groups (CKD-HTN 25 vs. pHTN 26%). Reduced mitral valve inflow Doppler E/A ratio, a marker of left ventricular diastolic dysfunction in echocardiogram, was more pronounced in CKD-HTN patents, in comparison to those with pHTN (p = 0.042). Also, diastolic function worsened with declining glomerular filtration rate in patients with CKD-HTN. Similarly, patients with CKD-HTN had a larger aortic root dimension when compared to patients with pHTN (p = 0.049). CONCLUSIONS: The prevalence of left ventricular diastolic dysfunction is similar in patients with pHTN and CKD-HTN. Patients with CKD-HTN appear to have more severe diastolic dysfunction and larger aortic root dimensions.


Subject(s)
Echocardiography, Doppler/statistics & numerical data , Hypertension/etiology , Renal Insufficiency, Chronic/complications , Ventricular Dysfunction, Left/diagnosis , Adolescent , Aorta/diagnostic imaging , Aorta/physiopathology , Blood Pressure/physiology , Blood Pressure Determination , Child , Child, Preschool , Diastole/physiology , Female , Glomerular Filtration Rate/physiology , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Hypertension/diagnosis , Male , Prevalence , Renal Insufficiency, Chronic/physiopathology , Retrospective Studies , Risk Factors , Ventricular Dysfunction, Left/epidemiology , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/physiopathology
13.
J Pediatr Genet ; 7(4): 180-184, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30430036

ABSTRACT

Hypertrophic cardiomyopathy (HCM) is the second most prevalent form of cardiomyopathy in children. The etiology of the HCM is heterogeneous, so is the age of onset of symptoms. The HCM associated with metabolic disorders and genetic syndromes presents early in childhood. There are very few case reports of early-onset infantile HCM secondary to the PRKAG2 gene. Here, we report a case of HCM in a neonate diagnosed prenatally and eventually diagnosed with a missense mutation in the PRKAG2 gene.

14.
Prenat Diagn ; 38(12): 958-963, 2018 11.
Article in English | MEDLINE | ID: mdl-30171818

ABSTRACT

OBJECTIVES: The objective of this study was to analyze the benefits associated with prenatal diagnosis of complex congenital heart disease (CHD) on preoperative morbidity, 30-day and 1-year mortality in this population. METHOD: This was a retrospective review of patients with complex CHD born at our tertiary care center over a 10-year period. Date analysis using Student t test and chi-square test. RESULTS: The overall rate of prenatal detection of complex CHD was 68.1%. A steady increase in the number of complex CHD diagnosed prenatally was noted during the study period. The prenatal diagnosis of complex CHD was associated with significant reduction in the incidence of the following preoperative parameters: antibiotic use, mechanical ventilation, inotropic support, hepatic and renal dysfunction, and acidosis. These beneficial effects were more significant in ductal-dependent cardiac anomalies. However, there were no neonatal and infant survival benefits in association with prenatal diagnosis. CONCLUSION: Prenatal diagnosis of complex CHD leads to improved preoperative morbidity, especially in patients with ductal-dependent cardiac anomalies. No survival benefits were noted with prenatal diagnosis of complex CHD.


Subject(s)
Heart Defects, Congenital/diagnostic imaging , Heart Defects, Congenital/epidemiology , Ultrasonography, Prenatal , Adult , Echocardiography/statistics & numerical data , Female , Heart Defects, Congenital/mortality , Humans , Infant , Infant Mortality , Infant, Newborn , Male , Pregnancy , Preoperative Period , Retrospective Studies , Survival Analysis , Ultrasonography, Prenatal/statistics & numerical data , Young Adult
15.
Cardiol Young ; 28(11): 1333-1337, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30060778

ABSTRACT

BACKGROUND: Enlargement of the left atrium is a non-invasive marker of diastolic dysfunction of the left ventricle, a determinant of prognosis in children with cardiomyopathy. Similarly, N-terminal prohormone brain natriuretic peptide is a useful marker in the management of children with cardiomyopathy and heart failure. The aim of this study is to evaluate the association of left atrial pressures with left atrial volume and N-terminal prohormone brain natriuretic peptide in children with cardiomyopathy. METHODS: This was a retrospective study reviewing the medical records of patients <18 years of age, who were diagnosed with cardiomyopathy or acute myocarditis with eventual development of cardiomyopathy. Left atrial volume by transthoracic echocardiogram and pulmonary capillary wedge pressure, a surrogate of left atrial pressure, obtained by means of cardiac catheterisation were analysed. In addition, N-terminal prohormone brain natriuretic peptide levels obtained at the time of the cardiac catheterisation were also reviewed. Statistical analysis was performed to evaluate the association of left atrial pressures with left atrial volume and N-terminal prohormone brain natriuretic peptide levels. RESULTS: There was a linear correlation of left atrial pressure estimated in the cardiac catheterisation with indexed left atrial volume (r=0.63; p<0.001) and left atrial volume z-scores (r=0.59; p<0.001). We found no statistically significant association between the left atrial pressure and N-terminal prohormone brain natriuretic peptide levels. CONCLUSIONS: Left atrial volume measured non-invasively by echocardiography can be used as a surrogate for left atrial pressure in assessing diastolic dysfunction of the left ventricle in children with cardiomyopathy. The larger the size of the left atrium, worse is the diastolic function of the left ventricle.


Subject(s)
Atrial Pressure/physiology , Cardiomyopathies/physiopathology , Heart Atria/physiopathology , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Adolescent , Biomarkers/blood , Cardiac Catheterization , Cardiomyopathies/blood , Cardiomyopathies/diagnosis , Child , Child, Preschool , Diastole , Echocardiography , Female , Heart Atria/diagnostic imaging , Humans , Infant , Male , Prognosis , Pulmonary Wedge Pressure , Retrospective Studies , Severity of Illness Index
16.
Congenit Heart Dis ; 13(5): 776-781, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30033665

ABSTRACT

INTRODUCTION: The Fontan operation is the final stage of single ventricle palliation in patients with complex congenital heart disease. Fenestration in the Fontan conduit, providing an atrial level right to left shunt, has been shown to reduce early postoperative morbidity. However, there is limited data on the long-term fate of this fenestration. The aim of this study is to define the rate of spontaneous closure of the fenestration in the Fontan conduit and factors predictive of the fate of the fenestration. METHODS: This was a retrospective study reviewing the medical records of the patients who underwent fenestrated Fontan operation at our center. Preoperative, intraoperative and postoperative variables including the status of the Fontan fenestration were extracted and analyzed. RESULTS: Of 67 patients included in the study, 15 (22%) had spontaneous closure of the fenestration. Of the remaining 52 patients, 11 (20%) had procedural closure of this fenestration (10 via cardiac catheterization and 1 via surgery) at a median duration of 3 months after the Fontan operation. Patients with higher preoperative pulmonary vascular resistance and a history of postoperative systemic venous thromboembolism had higher likelihood of having persistence of the fenestration with P value of .045 and .037, respectively. CONCLUSIONS: The rate of spontaneous closure of the Fontan fenestration was 22% in our study. Elevated preoperative pulmonary vascular resistance and history of systemic venous thromboembolism are predictive of persistent Fontan fenestration.


Subject(s)
Fontan Procedure/methods , Heart Defects, Congenital/surgery , Heart Ventricles/abnormalities , Postoperative Complications/epidemiology , Adolescent , Adult , Cardiac Catheterization/methods , Child , Child, Preschool , Female , Florida/epidemiology , Follow-Up Studies , Heart Defects, Congenital/diagnosis , Heart Ventricles/diagnostic imaging , Heart Ventricles/surgery , Humans , Incidence , Male , Retrospective Studies , Risk Factors , Young Adult
17.
BMJ Case Rep ; 20182018 May 12.
Article in English | MEDLINE | ID: mdl-29754141

ABSTRACT

Unilateral lung agenesis is a relatively rare congenital anomaly with a reported incidence of 1 in 15 000 births. It is frequently associated with other congenital malformations. Some of the sequelae of lung agenesis are potentially life-threatening. Here, we report a case of left lung agenesis in association with hiatal hernia and atrioventricular septal defect, a rare combination of anomalies which have not been described previously in the literature.


Subject(s)
Abnormalities, Multiple/diagnostic imaging , Heart Septal Defects/diagnostic imaging , Hernia, Hiatal/diagnostic imaging , Herniorrhaphy/methods , Lung Diseases/diagnostic imaging , Lung/abnormalities , Abnormalities, Multiple/physiopathology , Abnormalities, Multiple/therapy , Adult , Female , Gastrostomy/methods , Heart Septal Defects/physiopathology , Heart Septal Defects/therapy , Hernia, Hiatal/physiopathology , Hernia, Hiatal/therapy , Humans , Infant, Newborn , Infant, Premature , Lung/diagnostic imaging , Lung/physiopathology , Lung Diseases/physiopathology , Lung Diseases/therapy , Pregnancy , Referral and Consultation , Time Factors , Treatment Outcome
18.
Alcohol Clin Exp Res ; 42(6): 1051-1061, 2018 06.
Article in English | MEDLINE | ID: mdl-29602178

ABSTRACT

BACKGROUND: Conditioned stimuli (CS) that predict reward delivery acquire the ability to induce phasic dopamine release in the nucleus accumbens (NAc). This dopamine release may facilitate conditioned approach behavior, which often manifests as approach to the site of reward delivery (called "goal-tracking") or to the CS itself (called "sign-tracking"). Previous research has linked sign-tracking in particular to impulsivity and drug self-administration, and addictive drugs may promote the expression of sign-tracking. Ethanol (EtOH) acutely promotes phasic release of dopamine in the accumbens, but it is unknown whether an alcoholic reward alters dopamine release to a CS. We hypothesized that Pavlovian conditioning with an alcoholic reward would increase dopamine release triggered by the CS and subsequent sign-tracking behavior. Moreover, we predicted that chronic intermittent EtOH (CIE) exposure would promote sign-tracking while acute administration of naltrexone (NTX) would reduce it. METHODS: Rats received 14 doses of EtOH (3 to 5 g/kg, intragastric) or water followed by 6 days of Pavlovian conditioning training. Rewards were a chocolate solution with or without 10% (w/v) alcohol. We used fast-scan cyclic voltammetry to measure phasic dopamine release in the NAc core in response to the CS and the rewards. We also determined the effect of NTX (1 mg/kg, subcutaneous) on conditioned approach. RESULTS: Both CIE and alcoholic reward, individually but not together, associated with greater dopamine to the CS than control conditions. However, this increase in dopamine release was not linked to greater sign-tracking, as both CIE and alcoholic reward shifted conditioned approach from sign-tracking behavior to goal-tracking behavior. However, they both also increased sensitivity to NTX, which reduced goal-tracking behavior. CONCLUSIONS: While a history of EtOH exposure or alcoholic reward enhanced dopamine release to a CS, they did not promote sign-tracking under the current conditions. These findings are consistent with the interpretation that EtOH can stimulate conditioned approach, but indicate that the conditioned response may manifest as goal-tracking.


Subject(s)
Conditioning, Classical/drug effects , Dopamine/metabolism , Ethanol/pharmacology , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Reward , Animals , Cues , Electrochemical Techniques , Ethanol/antagonists & inhibitors , Male , Naltrexone/pharmacology , Rats
20.
J Pediatr Intensive Care ; 7(3): 169-172, 2018 Sep.
Article in English | MEDLINE | ID: mdl-31073490

ABSTRACT

Metformin is one of the most commonly used oral hypoglycemic agents in the treatment of type 2 diabetes mellitus. Toxicity related to accidental or intentional ingestion of metformin is well reported in the pediatric literature. We report a case of transient acute myocardial injury documented by biochemical and electrophysiological evidences in an adolescent male who presented with intentional ingestion of a large dose of metformin. To our knowledge, this is the first such case of documented reversible myocardial injury in relation to metformin toxicity to be reported in the pediatric literature.

SELECTION OF CITATIONS
SEARCH DETAIL
...